Shares of ValiRx plc (LON:VAL – Get Free Report) traded up 13.5% during mid-day trading on Wednesday . The company traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). 8,830,195 shares were traded during mid-day trading, a decline of 62% from the average session volume of 23,453,170 shares. The stock had previously closed at GBX 0.78 ($0.01).
ValiRx Stock Performance
The company’s 50 day simple moving average is GBX 1.07 and its 200 day simple moving average is GBX 1.71. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.27 and a current ratio of 6.65. The stock has a market cap of £1.10 million, a PE ratio of -41.60 and a beta of 0.59.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Dividend Payout Ratio Calculator
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
